Business
Mylan's Executive Chairman Robert Coury: we are well-positioned to quickly execute on the next strategic, value-enhancing opportunities for our business, some of which we...
Hi, what are you looking for?
Mylan's Executive Chairman Robert Coury: we are well-positioned to quickly execute on the next strategic, value-enhancing opportunities for our business, some of which we...
Mylan begins trading on the TASE; agrees to sell rights and assets related to seven generic drugs to secure regulatory approval of its hostile...
The hostile takeover bid for Perrigo Co. PLC continues with Mylan NV hosting a Tuesday, 5 pm, conference call to pitch the buyout...
Disney has been a winning stock since Bob Iger took over from Michael Eisner in 2005, with the stock rising 300%. Under Eisner’s guidance,...
Bill Ackman might be controversial, but he had the top performing hedge fund of 2014, as reported by Bloomberg. While he was ridiculed the...
A legal battle is raging on between Watchell and two partners against Carl Icahn over CVR Refining, a company that was once advised by...
Bill Ackman has cleaned up this year to the tune of $1 billion. He has also profited from Actavis’ announced merger with Botox maker...
The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical...
After an intense and acrimonious months long battle for a hostile takeover of Allergan, Bill Ackman, who owns a 9.7% stake in the company,...
On CNBC’s Mad Dash, Jim Cramer discussed Zoetis, an animal health biotech, that is a “gem of a company” spun off by Pfizer....